To the best of our knowledge, we are the first to report that the pretreatment combination of BMI and albumin levels along with CRP levels, which we defined as the NCR in the present study, is an independent indicator of a poor prognosis for patients with primary untreated colon cancer. The gene discussed is CRP; the disease is malignant colon neoplasm.